KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 87 filers reported holding KARUNA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,608 | -81.1% | 139,618 | -75.7% | 0.09% | -79.5% |
Q2 2023 | $124,603 | +39.7% | 574,606 | +17.0% | 0.43% | +33.2% |
Q1 2023 | $89,211 | -17.2% | 491,142 | -10.4% | 0.32% | -16.6% |
Q4 2022 | $107,745 | -99.9% | 548,321 | -21.1% | 0.39% | -32.4% |
Q3 2022 | $156,277,000 | +337.7% | 694,778 | +146.2% | 0.57% | +353.2% |
Q2 2022 | $35,705,000 | -23.8% | 282,230 | -23.6% | 0.13% | +0.8% |
Q1 2022 | $46,854,000 | +48.0% | 369,545 | +52.9% | 0.12% | +73.6% |
Q4 2021 | $31,664,000 | -16.9% | 241,705 | -22.4% | 0.07% | -20.9% |
Q3 2021 | $38,120,000 | -9.3% | 311,616 | -15.5% | 0.09% | -9.9% |
Q2 2021 | $42,022,000 | +11.5% | 368,646 | +17.6% | 0.10% | +5.2% |
Q1 2021 | $37,699,000 | +34.6% | 313,561 | +13.7% | 0.10% | +29.7% |
Q4 2020 | $28,011,000 | +34.6% | 275,727 | +2.5% | 0.07% | +12.1% |
Q3 2020 | $20,805,000 | -28.6% | 269,079 | +2.9% | 0.07% | -35.3% |
Q2 2020 | $29,152,000 | +29.1% | 261,544 | -16.6% | 0.10% | +2.0% |
Q1 2020 | $22,577,000 | +55.3% | 313,575 | +62.5% | 0.10% | +108.3% |
Q4 2019 | $14,537,000 | – | 192,963 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 2,912,872 | $369,323,000 | 52.78% |
Pivotal bioVenture Partners Investment Advisor LLC | 852,708 | $108,115,000 | 51.15% |
Sofinnova Investments, Inc. | 1,953,077 | $247,631,000 | 18.79% |
Nan Fung Group Holdings Ltd | 234,811 | $29,772,000 | 14.12% |
Sands Capital Ventures, LLC | 267,895 | $33,966,000 | 7.10% |
Logos Global Management LP | 340,000 | $43,109,000 | 5.59% |
DAFNA Capital Management LLC | 82,053 | $10,403,000 | 2.71% |
Ghost Tree Capital, LLC | 60,000 | $7,607,000 | 1.65% |
CATALYST PRIVATE WEALTH, LLC | 24,976 | $3,167,000 | 1.58% |
Eventide Asset Management | 748,000 | $94,839,000 | 1.49% |